PRIVI SPECIALITY CHEMICALS LIMITED
₹3,208.65-₹88.45 (-2.7%)
Last close · Data as of Oct 30, 2026
- Market cap
- ₹10,554 Cr
- P/E
- 37.8x
- EV / EBITDA
- 32.1x
- Revenue
- ₹2,038 Cr
- Net margin
- 5.7%
- ROCE
- 18.1%
Price chart
Technical chartScreen technicals →+13.3% over the last year
Daily closes.
Go deeper
Technical chart: candles, 9 moving averages, RSI, MACD and drawing tools
Performance
Price change over each period, before dividends.
- 1M
- -10.3%
- 3M
- -10.1%
- 6M
- -4.4%
- 1Y
- +13.3%
- 5Y
- +88.9%
52-week range
Day change -₹88.45 (-2.7%) from ₹3,297 to ₹3,209 · Last close Oct 30, 2026
Best weekday to invest, historically
The same weekly amount in PRIVISCL, bought on each weekday since 2021.
AI Summary
Indian StockStrengths1
- Strong cash conversion — FCF/PAT ratio of 0.85
Concerns0
Rule-based from financial data. Not advice.
About the company
Privi Speciality Chemicals Limited engages in the manufacture, supply, and export of aroma and fragrance chemicals in India, North America, Asia, the Middle East, Africa, Europe, South America, and the United Kingdom.
Read moreShow less
Privi Speciality Chemicals Limited engages in the manufacture, supply, and export of aroma and fragrance chemicals in India, North America, Asia, the Middle East, Africa, Europe, South America, and the United Kingdom. It offers a range of aroma chemicals, including alpha damascone, alpha ionone, alpha terpenyl acetate, amber fleur, amber gamma, beta iso damascol, BI perfumery grade, BI technical grade, carene-60 and carene-90, carvacrol, cedar ketol, citronellal, citronellol, citronellyl acetate, citronellyl nitrile, dipentene, double distilled turpentine oil, dihydro myrcenol, dihydromyrcene, galaxmusk, gamma methyl ionone, gamma terpenyl acetate, geraniol, geranyl acetate, Indian sandal core, ionone, iso boronyl acetate, isobornyl cyclohexanol, l-limonene, methyl ionone, nerol, neryl acetate, nimberol, OTBCHA, pine oil, prionyl, PTCBH, PTBCHA, rose oxide, sandal fleur, terpeniol alpha, terpeniol gamma, terpeniol BP grade, terpinolene, tetrahydroflorol, tetrahydrogeraniol, tetrahydrogeranyl acetate, tetrahydromyrcenol, timber forte, timber touch, eucalyptol, cineole, cyclademol, cyclamen aldehyde, indomeran, floravone, ambery woody extreme, camphor, and iso borneol commercial. The company was formerly known as Fairchem Speciality Limited and changed its name to Privi Speciality Chemicals Limited in October 2020. Privi Speciality Chemicals Limited was incorporated in 1985 and is based in Mumbai, India.
- Sector
- Materials
- Shares outstanding
- 3.9 Cr shares
- ISIN
- INE959A01019
- BSE code
- 530117
Key statistics
Screen fundamentals →Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.
Valuation
- Market cap
- ₹10,554 Cr
- P/E
- 37.8x
- P/B
- 8.4x
- EV / EBITDA
- 32.1x
- EV / Sales
- 6.6x
- P/S
- 6.2x
- Earnings yield
- 2.6%
- 52-week high
- ₹3,751.65
- 52-week low
- ₹2,622.35
Profitability
- Operating margin
- 19.2%
- Net margin
- 5.7%
- EBITDA margin
- 20.4%
- ROE
- 10.7%
- ROCE
- 18.1%
- ROA
- 4.5%
- Dividend payout
- 8.0%
- Tax rate
- 26.0%
- Other income, % of PBT
- 15.9%
Growth
- RevenueLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹2,038 Cr
- Revenue growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 19.0%
- Revenue CAGR, 5YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 5.7%
- EBITDALatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹350 Cr
- EBITDA growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 70.7%
- Net profit growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 92.9%
- Net profit CAGR, 5YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- -7.4%
- Cash from operationsLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹362 Cr
- CFO growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 558.2%
- Free cash flowLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹25.0 Cr
- Asset growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- -6.6%
Solvency and efficiency
- Current ratio
- 3.16
- Debt / Equity
- 0.98
- Debt / Assets
- 0.41
- Debt / EBITDA
- 2.57
- Interest coverage
- 3.39
- Financial leverage
- 2.38
- CFO / Net profit
- 3.69
- Cash / Market cap
- 10.4%
- Cash per share
- ₹282.08
- Asset turnover
- 0.78
- Fixed asset turnover
- 1.71
- Capital intensity
- 0.58
- Debtor days
- 77 days
- Inventory turnover
- 1.59
- Cash conversion cycle
- 198 days
Where the revenue went
Of every ₹100 of FY2025 revenue, ₹9 was left as net profit.
| From | To | Amount |
|---|---|---|
| Sales | Expenses | ₹1,590 Cr |
| Sales | Operating profit | ₹448 Cr |
| Operating profit | Interest | ₹85 Cr |
| Operating profit | Depreciation | ₹127 Cr |
| Operating profit | Profit before tax | ₹236 Cr |
| Other income | Profit before tax | ₹18 Cr |
| Profit before tax | Tax and other | ₹65 Cr |
| Profit before tax | Net profit | ₹189 Cr |
Revenue and net profit
Revenue grew 19.0% in FY2025; net profit is the dashed line.
| Date | Revenue | Net profit |
|---|---|---|
| FY2021 | ₹1,255 Cr | ₹117 Cr |
| FY2022 | ₹1,391 Cr | ₹102 Cr |
| FY2023 | ₹1,578 Cr | ₹22 Cr |
| FY2024 | ₹1,712 Cr | ₹98 Cr |
| FY2025 | ₹2,038 Cr | ₹189 Cr |
Cash flows
FY2025: ₹304 Cr from operations, ₹160 Cr free after investment (dashed).
| Date | Operating cash flow | Free cash flow |
|---|---|---|
| FY2021 | ₹152 Cr | -₹90 Cr |
| FY2022 | ₹15 Cr | -₹309 Cr |
| FY2023 | ₹55 Cr | -₹86 Cr |
| FY2024 | ₹362 Cr | ₹244 Cr |
| FY2025 | ₹304 Cr | ₹160 Cr |
Growth
Latest fiscal year FY2025 (ending March): each figure with its change over the year before.
- Revenue
- ₹2,038 Cr+19.0%1Y
- Net profit
- ₹189 Cr+92.9%1Y
- Cash from operations
- ₹304 Cr
- Free cash flow
- ₹160 Cr-34.4%1Y
- Revenue CAGR, 5Y
- 5.7%
- EBITDA CAGR, 5Y
- 4.5%
- Net profit CAGR, 5Y
- -7.4%
| Year | Revenue | Operating income | EBITDA | Net profit | CFO | FCF | ROE | Revenue growth 1Y | Net profit growth 1Y |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | ₹2,038 Cr | ₹448 Cr | — | ₹189 Cr | ₹304 Cr | ₹160 Cr | 17.2% | +19.0% | +92.9% |
Monthly returns
Month-by-month returns of PRIVISCL across the years, with the seasonal pattern.
Balance sheet
What the company owns and owes at the end of FY2025.
| Line | FY2025 |
|---|---|
| Liabilities and equity | ₹2,473 Cr |
| Equity capital | ₹39 Cr |
| Reserves | ₹1,062 Cr |
| Borrowings | ₹856 Cr |
| Other liabilities | ₹516 Cr |
| Assets | ₹2,473 Cr |
| Fixed assets | ₹979 Cr |
| Capital work in progress | ₹70 Cr |
| Investments | ₹62 Cr |
| Other assets | ₹1,363 Cr |
Market cap against peers
8 peers: same sector group, nearest by size.
P/E against peers
PRIVISCL trades at 37.8x earnings against a peer median of 35.5x.
Not shown (no positive earnings and no EV / Sales): NMDC Steel Limited.
Peer comparison
Same-sector peers by market cap, with the median.
| Company | Market cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|
| PRIVI SPECIALITY CHEMICALS LIMITEDPRIVISCLthis company | ₹10,554 Cr | 37.8x | 8.4x | 10.7% | 32.1x |
| Nuvoco Vistas Corporation LimitedNUVOCO | ₹12,637 Cr | 64.8x | 1.4x | 1.7% | 12.5x |
| NMDC Steel LimitedNSLNISP | ₹12,244 Cr | — | 0.9x | -10.1% | -13.2x |
| GRAVITA INDIA LIMITEDGRAVITA | ₹11,994 Cr | 45.6x | 7.0x | 39.4% | 47.6x |
| PCBL Chemical LimitedPCBL | ₹11,042 Cr | 30.8x | 2.7x | 16.3% | 13.6x |
| Jubilant Ingrevia LimitedJUBLINGREA | ₹10,899 Cr | 39.8x | 4.3x | 7.2% | 26.2x |
| Supreme Petrochem Ltd.SPLPETRO | ₹10,605 Cr | 34.5x | 4.8x | — | — |
| JK Lakshmi Cement LimitedJKLAKSHMI | ₹9,438 Cr | 20.4x | 2.5x | 14.9% | 9.9x |
| Clean Science and Technology LimitedCLEAN | ₹9,091 Cr | 30.9x | 5.9x | 20.4% | 24.0x |
| Peer median | — | 35.5x | 3.7x | 12.9% | 19.2x |
Year-to-date ROI
PRIVISCL since 1 January, against earlier years.
Historical volatility
PRIVISCL's day-to-day swings over 30, 60 and 180 days.
Financial statements
Income statement, balance sheet and cash flow as reported, in ₹ crore, grouped into plain-language lines.
Figures in ₹ crore as reported, fiscal years ending March, newest first; the trailing twelve months (TTM) last.
Operating margin by fiscal year
| Date | Operating margin |
|---|---|
| FY2021 | 16.0% |
| FY2022 | 14.0% |
| FY2023 | 12.0% |
| FY2024 | 19.0% |
| FY2025 | 22.0% |
| Line | FY2025 |
|---|---|
| RevenueSales | ₹2,038 Cr |
| Costs | |
| Interest | ₹85 Cr |
| Expenses | ₹1,590 Cr |
| Operating profitOperating Profit | ₹448 Cr |
| Other income and charges | |
| Profit before tax | ₹254 Cr |
| Tax | |
| Net profitNet Profit | ₹189 Cr |
| Per share |
| Line | FY2025 |
|---|---|
| Liabilities and equityTotal Liabilities | ₹2,473 Cr |
| Equity capitalEquity Capital | ₹39 Cr |
| Reserves | ₹1,062 Cr |
| Borrowings | ₹856 Cr |
| Other liabilitiesOther Liabilities | ₹516 Cr |
| AssetsTotal Assets | ₹2,473 Cr |
| Fixed assetsFixed Assets | ₹979 Cr |
| Capital work in progressCWIP | ₹70 Cr |
| Investments | ₹62 Cr |
| Other assetsOther Assets | ₹1,363 Cr |
| Line | FY2025 |
|---|---|
| Operating cash flowCash from Operating Activity | ₹304 Cr |
| Investing cash flowCash from Investing Activity | -₹144 Cr |
| Financing cash flowCash from Financing Activity | -₹135 Cr |
| Change in cashNet Cash Flow | ₹25 Cr |
Learn while you research
Academy chapters picked for PRIVI SPECIALITY CHEMICALS LIMITED and the metrics on this page.
- 01 Taxes on Investments (India)LTCG, STCG, dividend tax, what every Indian investor needs.6 min read
- 02 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
- 03 Valuation Multiples ExplainedThis stock trades at a P/E of 37.8, learn when high multiples are justified.6 min read
- 04 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
- 05 Business Cycles & StocksThese cyclical sectors win and lose in different macro phases.6 min read
- 06 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read